Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edward Thomas Ryan, D.T.M.&H., M.D.

Concepts

This page shows the publications Edward Ryan has written about Middle Aged.
Connection Strength

0.383
  1. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba. PLoS Negl Trop Dis. 2019 11; 13(11):e0007874.
    View in: PubMed
    Score: 0.018
  2. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. PLoS Negl Trop Dis. 2018 04; 12(4):e0006399.
    View in: PubMed
    Score: 0.016
  3. Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh. J Infect Dis. 2017 07 01; 216(1):125-134.
    View in: PubMed
    Score: 0.016
  4. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh. Clin Vaccine Immunol. 2016 05; 23(5):427-435.
    View in: PubMed
    Score: 0.014
  5. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice. PLoS Negl Trop Dis. 2015; 9(7):e0003881.
    View in: PubMed
    Score: 0.014
  6. Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3076.
    View in: PubMed
    Score: 0.013
  7. Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol. 2014 Mar; 21(3):280-5.
    View in: PubMed
    Score: 0.012
  8. Non-typhoidal Salmonella gastroenteritis at a diarrheal hospital in Dhaka, Bangladesh, 1996-2011. Am J Trop Med Hyg. 2013 Apr; 88(4):661-9.
    View in: PubMed
    Score: 0.011
  9. In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1419.
    View in: PubMed
    Score: 0.011
  10. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin Vaccine Immunol. 2011 Aug; 18(8):1317-25.
    View in: PubMed
    Score: 0.010
  11. Interferon-? and proliferation responses to Salmonella enterica Serotype Typhi proteins in patients with S. Typhi Bacteremia in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2011 Jun; 5(6):e1193.
    View in: PubMed
    Score: 0.010
  12. Analysis of Salmonella enterica serotype paratyphi A gene expression in the blood of bacteremic patients in Bangladesh. PLoS Negl Trop Dis. 2010 Dec 07; 4(12):e908.
    View in: PubMed
    Score: 0.010
  13. Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. J Travel Med. 2010 Nov-Dec; 17(6):387-91.
    View in: PubMed
    Score: 0.010
  14. Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology. Clin Vaccine Immunol. 2010 Aug; 17(8):1188-95.
    View in: PubMed
    Score: 0.010
  15. Case records of the Massachusetts General Hospital. Case 29-2007. A 51-year-old man with gastric cancer and lung nodules. N Engl J Med. 2007 Sep 20; 357(12):1239-46.
    View in: PubMed
    Score: 0.008
  16. Case records of the Massachusetts General Hospital. Case 39-2005. A 63-year-old woman with a positive serologic test for syphilis and persistent eosinophilia. N Engl J Med. 2005 Dec 22; 353(25):2697-705.
    View in: PubMed
    Score: 0.007
  17. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera. mSphere. 2021 04 28; 6(2).
    View in: PubMed
    Score: 0.005
  18. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021 03; 27(3):454-462.
    View in: PubMed
    Score: 0.005
  19. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin Chem. 2020 12 01; 66(12):1562-1572.
    View in: PubMed
    Score: 0.005
  20. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 10 30; 11(1):5493.
    View in: PubMed
    Score: 0.005
  21. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020 10 08; 5(52).
    View in: PubMed
    Score: 0.005
  22. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh. Int J Infect Dis. 2020 Dec; 101:220-225.
    View in: PubMed
    Score: 0.005
  23. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19. Nat Biomed Eng. 2020 12; 4(12):1180-1187.
    View in: PubMed
    Score: 0.005
  24. Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital. FASEB J. 2020 10; 34(10):13877-13884.
    View in: PubMed
    Score: 0.005
  25. Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nat Biotechnol. 2020 10; 38(10):1174-1183.
    View in: PubMed
    Score: 0.005
  26. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. Immunity. 2020 09 15; 53(3):524-532.e4.
    View in: PubMed
    Score: 0.005
  27. Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium. J Travel Med. 2019 09 02; 26(6).
    View in: PubMed
    Score: 0.005
  28. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh. PLoS Negl Trop Dis. 2019 08; 13(8):e0007634.
    View in: PubMed
    Score: 0.005
  29. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever. Clin Infect Dis. 2019 03 05; 68(6):949-955.
    View in: PubMed
    Score: 0.004
  30. Estimating cholera incidence with cross-sectional serology. Sci Transl Med. 2019 02 20; 11(480).
    View in: PubMed
    Score: 0.004
  31. Emergence of Extensively Drug-Resistant Salmonella Typhi Infections Among Travelers to or from Pakistan - United States, 2016-2018. MMWR Morb Mortal Wkly Rep. 2019 Jan 11; 68(1):11-13.
    View in: PubMed
    Score: 0.004
  32. Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults. Microbes Infect. 2019 Apr - May; 21(3-4):176-183.
    View in: PubMed
    Score: 0.004
  33. High Rates of Enteric Fever Diagnosis and Lower Burden of Culture-Confirmed Disease in Peri-urban and Rural Nepal. J Infect Dis. 2018 11 10; 218(suppl_4):S214-S221.
    View in: PubMed
    Score: 0.004
  34. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. Lancet Infect Dis. 2018 11; 18(11):1229-1240.
    View in: PubMed
    Score: 0.004
  35. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. J Infect Dis. 2018 07 13; 218(4):645-653.
    View in: PubMed
    Score: 0.004
  36. Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools. PLoS Negl Trop Dis. 2018 03; 12(3):e0006286.
    View in: PubMed
    Score: 0.004
  37. HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study. Lung. 2018 02; 196(1):49-57.
    View in: PubMed
    Score: 0.004
  38. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine. MMWR Morb Mortal Wkly Rep. 2017 May 12; 66(18):482-485.
    View in: PubMed
    Score: 0.004
  39. Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016. Emerg Infect Dis. 2017 02; 23(2):324-327.
    View in: PubMed
    Score: 0.004
  40. Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults. PLoS Negl Trop Dis. 2016 06; 10(6):e0004753.
    View in: PubMed
    Score: 0.004
  41. Development of a Simple, Peripheral-Blood-Based Lateral-Flow Dipstick Assay for Accurate Detection of Patients with Enteric Fever. Clin Vaccine Immunol. 2016 05; 23(5):403-409.
    View in: PubMed
    Score: 0.004
  42. Comparison of the Performance of the TPTest, Tubex, Typhidot and Widal Immunodiagnostic Assays and Blood Cultures in Detecting Patients with Typhoid Fever in Bangladesh, Including Using a Bayesian Latent Class Modeling Approach. PLoS Negl Trop Dis. 2016 Apr; 10(4):e0004558.
    View in: PubMed
    Score: 0.004
  43. Pre-Travel Medical Preparation of Business and Occupational Travelers: An Analysis of the Global TravEpiNet Consortium, 2009 to 2012. J Occup Environ Med. 2016 Jan; 58(1):76-82.
    View in: PubMed
    Score: 0.004
  44. Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014. PLoS Negl Trop Dis. 2015 Nov; 9(11):e0004183.
    View in: PubMed
    Score: 0.003
  45. Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015 Nov; 93(5):1110-1116.
    View in: PubMed
    Score: 0.003
  46. Cholera in pregnancy: Clinical and immunological aspects. Int J Infect Dis. 2015 Oct; 39:20-4.
    View in: PubMed
    Score: 0.003
  47. Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses. PLoS Negl Trop Dis. 2015 Apr; 9(4):e0003619.
    View in: PubMed
    Score: 0.003
  48. Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection. J Infect Dis. 2015 Sep 01; 212(5):779-83.
    View in: PubMed
    Score: 0.003
  49. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2014 Oct; 91(4):738-42.
    View in: PubMed
    Score: 0.003
  50. Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet. Am J Trop Med Hyg. 2014 Oct; 91(4):694-698.
    View in: PubMed
    Score: 0.003
  51. Pre-travel preparation of US travelers going abroad to provide humanitarian service, Global TravEpiNet 2009-2011. Am J Trop Med Hyg. 2014 Mar; 90(3):553-559.
    View in: PubMed
    Score: 0.003
  52. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine. Clin Vaccine Immunol. 2013 Oct; 20(10):1541-8.
    View in: PubMed
    Score: 0.003
  53. Evaluation of a typhoid/paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2013; 7(7):e2316.
    View in: PubMed
    Score: 0.003
  54. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011. Am J Trop Med Hyg. 2013 May; 88(5):954-961.
    View in: PubMed
    Score: 0.003
  55. Pre-travel health care of immigrants returning home to visit friends and relatives. Am J Trop Med Hyg. 2013 Feb; 88(2):376-380.
    View in: PubMed
    Score: 0.003
  56. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection. Clin Vaccine Immunol. 2013 Jan; 20(1):17-23.
    View in: PubMed
    Score: 0.003
  57. Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh. Am J Trop Med Hyg. 2012 Nov; 87(5):921-6.
    View in: PubMed
    Score: 0.003
  58. Myocardial infarction mimicked by acute cholecystitis. Ann Intern Med. 1992 Feb 01; 116(3):218-20.
    View in: PubMed
    Score: 0.003
  59. Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1413.
    View in: PubMed
    Score: 0.003
  60. Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis. 2012 Feb 15; 54(4):455-62.
    View in: PubMed
    Score: 0.003
  61. Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. Clin Vaccine Immunol. 2011 Aug; 18(8):1371-7.
    View in: PubMed
    Score: 0.003
  62. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2011 May; 18(5):844-50.
    View in: PubMed
    Score: 0.003
  63. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1. Scand J Infect Dis. 2010; 42(1):48-56.
    View in: PubMed
    Score: 0.002
  64. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009 Nov 15; 49(10):1473-9.
    View in: PubMed
    Score: 0.002
  65. Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever. Clin Vaccine Immunol. 2009 Nov; 16(11):1587-94.
    View in: PubMed
    Score: 0.002
  66. Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun. 2009 Nov; 77(11):5090-6.
    View in: PubMed
    Score: 0.002
  67. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun. 2009 Sep; 77(9):3850-6.
    View in: PubMed
    Score: 0.002
  68. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J. 2008 Nov; 27(11):986-92.
    View in: PubMed
    Score: 0.002
  69. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis. 2008 Apr 09; 2(4):e221.
    View in: PubMed
    Score: 0.002
  70. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005 Nov; 73(11):7422-7.
    View in: PubMed
    Score: 0.002
  71. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol. 1988 Dec; 29(4):189-94.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.